Currently the price is 0,09$, Statera Biopharma Inc, with address at 2537 RESEARCH BOULEVARD SUITE 201, FORT COLLINS, Colorado, 80526, United States, is a publicly traded company and its visible heads at the moment are Andrei V. Gudkov (Global Head-Research & Development), Clifford A. Selsky (Chief Medical Officer), James Mendolera (Director-Information Technology), Michael Kevin Handley (President, Chief Executive Officer & Director), Peter J. Aronstam (Chief Financial Officer), Robert W. Buckheit (Chief Technology Officer), Taunia S. Markvicka (Chief Operating Officer & Director). Focused on Biotechnology: Pharmaceutical Preparations was created long ago in United States.
Yesterday this stock ended the day with a value of desconocido$.
The current range on the same day is from 0,09$ - 0,11$, with a percentage difference of 0,10$ quite wide that helps to be able to do day trading.
Their latest annual data shows an income of desconocido.
The last value we have registered for the opening is desconocido.
One of the most interesting values to assess whether the price of a share is low or high is the minimum and maximum price of the last 52 weeks, in this case it has varied between 0,00$ and 0,00$.
Earnings per share, or EPS, is a value also used to assess whether a company has obtained sufficient net profits for the number of shares it has for sale. In this case it is [BPA], but it must be taken into account that there may have been increases or decreases in capital that influence the value.
Buscar
